Ajanta Pharmaceuticals

Ajanta Pharmaceuticals

AJANTPHARM

 ₹ 2,713.63
- ₹ 9.74
0.36%
Healthcare
 ₹ 0.00
(%)1D
Updated: 26 Mar 2025, 03:30:56 pm IST
Stock Score
Open Price
 ₹ 2,729.98
Prev. Close
 ₹ 2,723.37
 ₹ 2,689.09
Day Low
 ₹ 2,751.10
Day High

 ₹ 2,160.74
52 Week Low
 ₹ 3,459.84
52 Week High

Quick Bite

Price To Earnings Ratio

41.86

Sector PE

64.22

PB Ratio

9.59

Sector PB

8.24

EPS

64.83

Dividend Yield

2.28

Today's Volume

90.304 K

5 Day Avg. Volume

280.012 K

PEG Ratio

1.08

Market Cap.

₹ 33,900.00 Cr.

News & Events

About Ajanta Pharmaceuticals

Ajanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.

Ajanta Pharmaceuticals Share Price

Ajanta Pharma Limited is an Indian company primarily engaged in the development, manufacture and distribution of ready-made specialty medicines. The company's marketing network operates in domestic and international markets. The company produces a wide range of specialty products targeting different therapeutic segments for patient care and tailored to each market area in which it operates. The generic sea trade is spread across India and about 30 developing countries in Africa, Southeast Asia and West Asia and the Commonwealth of Independent States (CIS). Its product range includes advanced technology products. The company has also made significant investments in its research and development (R&D) facilities.

Ajanta Pharmaceuticals FAQs

How to Buy Ajanta Pharmaceuticals Share?

up
To purchase Ajanta Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Ajanta Pharmaceuticals (ticker symbol: AJANTPHARM) on the trading platform provided by your broker and purchase the shares.

What's Ajanta Pharmaceuticals share price today?

up
The stock price of Ajanta Pharmaceuticals as of 02 Apr 2025 is ₹2,713.63

What is the Market Cap of Ajanta Pharmaceuticals?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 02 Apr 2025, Ajanta Pharmaceuticals (ticker symbol: AJANTPHARM) has a market capitalisation of approximately ₹3,39,00,00,00,000.00

What is the PE and PB ratio of Ajanta Pharmaceuticals?

up
Ajanta Pharmaceuticals Ltd's price-to-book ratio as of 02 Apr 2025 is 9.59, reflecting the market's valuation compared to its asset value. As of 02 Apr 2025, the trailing twelve months P/E (price-to-earnings) ratio is 41.86, indicating the market values the company at around ₹41.86 for every ₹1 of earnings

What is the 52 Week High and Low of Ajanta Pharmaceuticals Share?

up
Ajanta Pharmaceuticals Ltd (AJANTPHARM) hit its 52-week high at ₹3,459.84, and its 52-week low at ₹2,160.74.
Begin your investment journey today
Login/Register
Start Now